Bellwether is a UW Genomics start-up developing new tools to enable early detection of cancer and other diseases through "Liquid Biopsy," The company's technology can be used to trace tell-tale DNA fragments circulating within a patient's blood to the tissues/organs of origin.

Click here to access the company's website.